| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f314cc46ec1429ce159f3daf762885c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7fd38ff393036b78f4fa402ddeeae2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_516fdf3a7f5bd547b2d9ae14dd8fa9ec |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
| filingDate |
2003-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c49e3b89932b12c7afcbfcaccbcae9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c796f32d620f36923e873e5423f43bee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f602e3842ce62d60b54a6739a246b35f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_824c1f64c5bfc7829c8f52526f6e6d08 |
| publicationDate |
2005-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1558261-A2 |
| titleOfInvention |
Quinazolinone compositions for regulation of gene expression related to pathological processes |
| abstract |
The present invention relates to pharmaceutical compositions for modifying gene expression in a pathological process, thereby preventing or ameliorating said process. More particularly the compositions comprise quinazolinones, especially halofuginone, for inhibiting or preventing alterations in gene expression during fibrosis. The present invention particularly relates to pharmaceutical compositions for improving the regeneration of cirrhotic liver. |
| priorityDate |
2002-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |